Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 131 clinical trials
None
Radial Versus Femoral Arterial Access for Cerebral Angiography in Adolescents

This study will compare radial vs femoral access for angiography in adolescents. Neuroangiography and neurointerventions are predominantly performed via femoral access, which has several limitations and complications - pain and discomfort, arterial occlusion, retroperitoneal hemorrhage, activity limitations, and increased admissions. Transradial angiography has shown promise to circumvent these problems, but …

  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Bovine Colostrum as a Fortifier Added to Human Milk for Preterm Infants

the high risk of late-onset sepsis (LOS), related to their immature immunity in gut and blood. Conversely, too fast increase of EN predisposes to feeding intolerance and necrotizing enterocolitis (NEC

enteral nutrition
sepsis
very low birth weight
  • 8 views
  • 27 Mar, 2021
  • 7 locations
None
T-VEC in Non-melanoma Skin Cancer

Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) in patients with locally advanced non-melanoma skin cancer.

skin cancer
melanoma skin
carcinoma of skin
lymphoma
squamous cell carcinoma
  • 38 views
  • 26 Mar, 2021
  • 1 location
None
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

The I-MAT trial is a randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma aiming to explore the efficacy of avelumab as adjuvant immunotherapy.

immunomodulator
avelumab
18f-fdg
renal function
carcinoma
  • 1 views
  • 28 Jul, 2021
  • 20 locations
None
Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Patients with advanced gastrointestinal (GI) cancers are very often sarcopenic/malnourished at diagnosis (> 60% of cases) and at high risk of rapid clinical deterioration. These patients have important supportive care needs that represent a major challenge for improving treatment tolerance and patient survival and health-related quality of life (HRQoL). Malnutrition …

  • 0 views
  • 08 Sep, 2021
  • 1 location
None
Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material

Non-surgical root canal therapy (RCT) represents a standard of treatment that addresses infected pulp tissue in teeth and protects against future infection while preserving the tooth for the patient for mainly cosmetic purposes. RCT is offered as the better cosmetic, cheaper, and less time intensive treatment option for a patient …

root canal therapy
root canal filling
  • 59 views
  • 26 Jan, 2021
  • 1 location
None
Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy

The purpose of this study is to to compare root canal therapy success between two root canal filler materials: 1) gutta percha (GP), 2) gutta percha modified with nanodiamonds and amoxicillin (NDGX). Gutta percha is the current standard root canal filler material used during non-surgical root canal therapy (RCT). Gutta …

root canal therapy
amoxicillin
  • 34 views
  • 26 Jan, 2021
  • 1 location
None
Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants

The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We

  • 0 views
  • 16 May, 2021
  • 1 location
None
Bovine Colostrum as a Human Milk Fortifier for Preterm Infants

), related to their immature immunity in gut and blood. Conversely, too fast increase of EN predisposes to feeding intolerance and necrotizing enterocolitis (NEC). Further, human milk feeding is not

enteral nutrition
sepsis
  • 0 views
  • 25 Mar, 2021
  • 2 locations
None
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

The 1100 study is an open-label, Phase I, prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy.

nbtxr3
cancer
  • 13 views
  • 05 Feb, 2021
  • 10 locations